Earnings Estimates
Target Price Summary
Current Trading Price: $ 15.82
| Mean: | $ 23.20 |
| Median: | $ 21.50 |
| High: | $ 30.00 |
| Low: | $ 19.00 |
* 6 analysts reported target price for MAP Pharmaceuticals, Inc.
Analyst Estimates
| Earnings Per Share |
Current Quarter
Dec 2011 |
Next Quarter
Mar 2012 |
Current Year
Dec 2011 |
Next Year
Dec 2012 |
|---|---|---|---|---|
| Consensus | $ -0.33 | $ -0.34 | $ 0.32 | $ 0.46 |
| High | $ -0.27 | $ -0.34 | $ 0.37 | $ 3.52 |
| Low | $ -0.51 | $ -0.34 | $ 0.15 | $ -1.27 |
| P/E | N/A | N/A | 49.44 | 34.45 |
| Year Ago EPS | $ -0.46 | $ 0.56 | $ -2.01 | $ 0.32 |
| Number of Analyst(s) | 5 | 1 | 5 | 6 |
| Revision(s) Up Last 30 Days |
0 | 0 | 0 | 1 |
| Revision(s) Down Last 30 Days |
0 | 0 | 0 | 0 |
Estimate Analysis
Disclaimer: Average earnings estimates are calculated by FactSet based on their earnings projections made by the analysts who cover MAP Pharmaceuticals, Inc. Please note that any opinions, estimates or forecasts regarding MAP Pharmaceuticals, Inc.'s performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of MAP Pharmaceuticals, Inc. or its management. MAP Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
